SNWV
Income statement / Annual
Last year (2025), Sanuwave Health Inc's total revenue was $44.05 M,
an increase of 34.98% from the previous year.
In 2025, Sanuwave Health Inc's net income was $11.81 M.
See Sanuwave Health Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$44.05 M |
$32.63 M |
$20.40 M |
$16.74 M |
$13.01 M |
$4.06 M |
$1.03 M |
$1.85 M |
$738.53 K |
$1.38 M |
| Cost of Revenue |
$10.96 M
|
$8.08 M
|
$6.04 M
|
$4.33 M
|
$4.99 M
|
$1.16 M
|
$538.92 K
|
$693.66 K
|
$241.97 K
|
$565.13 K
|
| Gross Profit |
$33.09 M
|
$24.55 M
|
$14.36 M
|
$12.41 M
|
$8.02 M
|
$2.90 M
|
$489.81 K
|
$1.16 M
|
$496.56 K
|
$810.93 K
|
| Gross Profit Ratio |
0.75
|
0.75
|
0.7
|
0.74
|
0.62
|
0.71
|
0.48
|
0.63
|
0.67
|
0.59
|
| Research and Development Expenses |
$1.35 M
|
$673.00 K
|
$579.00 K
|
$567.00 K
|
$1.10 M
|
$1.25 M
|
$1.18 M
|
$1.66 M
|
$1.29 M
|
$1.13 M
|
| General & Administrative Expenses |
$19.37 M
|
$11.35 M
|
$8.67 M
|
$12.56 M
|
$11.69 M
|
$13.72 M
|
$6.44 M
|
$6.81 M
|
$3.00 M
|
$2.67 M
|
| Selling & Marketing Expenses |
$7.42 M
|
$6.32 M
|
$4.90 M
|
$7.47 M
|
$8.59 M
|
$5.16 M
|
$1.59 M
|
$521.41 K
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$26.79 M
|
$17.67 M
|
$13.57 M
|
$20.03 M
|
$20.28 M
|
$18.88 M
|
$8.03 M
|
$7.33 M
|
$3.00 M
|
$2.67 M
|
| Other Expenses |
$0.00
|
$789.00 K
|
$752.00 K
|
$766.00 K
|
$784.00 K
|
$7.97 M
|
$71.21 K
|
$9.95 K
|
$0.00
|
$326.61 K
|
| Operating Expenses |
$28.14 M
|
$19.13 M
|
$14.90 M
|
$21.36 M
|
$22.17 M
|
$28.10 M
|
$9.28 M
|
$8.34 M
|
$4.32 M
|
$4.13 M
|
| Cost And Expenses |
$39.11 M
|
$27.22 M
|
$20.94 M
|
$25.69 M
|
$27.15 M
|
$29.26 M
|
$9.82 M
|
$9.03 M
|
$4.56 M
|
$4.69 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$6.25 M
|
$13.64 M
|
$15.62 M
|
$14.13 M
|
$7.10 M
|
$2.54 M
|
$1.84 M
|
$4.50 M
|
$1.14 M
|
$854.98 K
|
| Depreciation & Amortization |
$1.28 M
|
$1.15 M
|
$1.03 M
|
$952.00 K
|
$1.24 M
|
$1.01 M
|
$71.21 K
|
$22.33 K
|
$24.07 K
|
$326.61 K
|
| EBITDA |
$6.23 M |
-$16.56 M |
-$9.15 M |
$4.79 M |
-$18.90 M |
-$27.38 M |
-$8.52 M |
-$7.11 M |
-$4.37 M |
-$2.99 M |
| EBITDA Ratio |
0.14
|
-0.51
|
-0.45
|
0.29
|
-1.45
|
-6.75
|
-8.28
|
-3.84
|
-5.92
|
-2.17
|
| Operating Income Ratio |
0.11
|
0.17
|
-0.03
|
-0.53
|
-1.09
|
-6.21
|
-8.55
|
-3.88
|
-5.18
|
-2.41
|
| Total Other Income/Expenses Net |
$6.95 M
|
-$36.76 M
|
-$25.26 M
|
-$1.34 M
|
-$13.09 M
|
-$5.74 M
|
-$1.64 M
|
-$4.45 M
|
-$1.71 M
|
-$3.12 M
|
| Income Before Tax |
$11.90 M
|
-$31.35 M
|
-$25.80 M
|
-$10.29 M
|
-$27.23 M
|
-$30.94 M
|
-$10.43 M
|
-$11.63 M
|
-$5.54 M
|
-$6.44 M
|
| Income Before Tax Ratio |
0.27
|
-0.96
|
-1.26
|
-0.61
|
-2.09
|
-7.63
|
-10.14
|
-6.29
|
-7.5
|
-4.68
|
| Income Tax Expense |
$86.00 K
|
$27.00 K
|
$4.00 K
|
$2.00 K
|
$28.00 K
|
$0.00
|
$0.00
|
$45.01 K
|
$0.00
|
$3.12 M
|
| Net Income |
$11.81 M
|
-$31.37 M
|
-$25.81 M
|
-$10.29 M
|
-$27.26 M
|
-$30.94 M
|
-$10.43 M
|
-$11.63 M
|
-$5.54 M
|
-$6.44 M
|
| Net Income Ratio |
0.27
|
-0.96
|
-1.27
|
-0.61
|
-2.1
|
-7.63
|
-10.14
|
-6.29
|
-7.5
|
-4.68
|
| EPS |
1.38 |
-7.03 |
-12.19 |
-7.02 |
-19.72 |
-30.68 |
-19.2638 |
-29.1675 |
-15 |
-22.5 |
| EPS Diluted |
0.41 |
-7.03 |
-12.19 |
-7.02 |
-19.72 |
-30.68 |
-19.2638 |
-29.1675 |
-15 |
-22.5 |
| Weighted Average Shares Out |
$8.56 M
|
$4.46 M
|
$2.12 M
|
$1.47 M
|
$1.38 M
|
$1.01 M
|
$541.44 K
|
$398.77 K
|
$370.24 K
|
$286.99 K
|
| Weighted Average Shares Out Diluted |
$9.08 M
|
$4.46 M
|
$2.12 M
|
$1.47 M
|
$1.38 M
|
$1.01 M
|
$541.44 K
|
$398.77 K
|
$370.24 K
|
$286.99 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
